Influence of androgen therapy on lacrimal autoimmune disease in a mouse model of Sjögren's syndrome.
Sullivan
D A
DA
Department of Ophthalmology, Harvard Medical School Immunology Unit, Schepens Eye Research Institute, Boston, MA 02114, USA.
Rocha
F J
FJ
Sato
E H
EH
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D018928:Immunity, Mucosal; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007765:Lacrimal Apparatus / Q000187:drug effects / Q000276:immunology; D007766:Lacrimal Apparatus Diseases / Q000188:drug therapy* / Q000276:immunology; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D051379:Mice; D012859:Sjogren's Syndrome / Q000188:drug therapy* / Q000276:immunology; D013256:Steroids / Q000627:therapeutic use; D013363:Submandibular Gland / Q000187:drug effects / Q000276:immunology; D045165:Testosterone Congeners / Q000627:therapeutic use*
D007071:Immunoglobulin A, Secretory; D007166:Immunosuppressive Agents; D013256:Steroids; D045165:Testosterone Congeners